Microvideos aim to boost HPV shots in young cancer survivors
NCT ID NCT07648953
First seen Jun 16, 2026 · Last updated Jun 23, 2026 · Updated 3 times
Summary
This study tests whether short educational videos can help young adults who survived childhood cancer learn about and get the HPV vaccine. The researchers will enroll 55 survivors aged 18-26 who haven't finished the vaccine series. Participants will watch the videos on Facebook and answer surveys to see if this approach is practical and well-liked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV VACCINATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
microvideos (HPV vaccination education)
What this could lead to
If successful, this approach could provide a simple, scalable way to increase HPV vaccination rates among childhood cancer survivors, reducing their risk of HPV-related cancers.
What could go wrong
This is a small, early-stage study with only 55 participants, focused on feasibility rather than proving the videos actually increase vaccination rates. Results may not apply to other groups or settings.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.